Jacksonville, FL – SCRI Cardiovascular, a division of Sarah Cannon Research Institute (SCRI), one of the world’s leading clinical research programs, is partnering with Memorial Hospital to provide patients access to cutting-edge clinical trials in Northeast Florida. As a leader in cardiovascular research, SCRI Cardiovascular provides a foundation for evidence-based strategies that facilitate optimal and cost-effective patient care. Clinical trial options are currently available at Memorial Hospital.
“Our unique collaboration with SCRI is an example of our hospital’s commitment to providing the latest advancements in cardiovascular techniques and innovation,” said Memorial Hospital President & CEO Jim O’Loughlin. “With more than 50 clinical trials currently taking place at Memorial, we are able to serve as an epicenter of cardiovascular research and provide our patients with access to the newest cardiovascular therapies available today.”
Under the leadership of Dr. Van Crisco, the program will develop a clinical research program with a focus on cardiovascular drug and device development. Dr. Crisco is an experienced clinician with more than 13 years of research experience in stem cell, peripheral and coronary trials. Memorial Hospital provides advanced cardiology services which include Diagnostic and Interventional Cardiac and Peripheral Procedures, Chronic Total Occlusion Revascularization (CTO), Alcohol Septal Ablations, Carotid Stenting, PFO Closures, Tilt Table Testing, Electrophysiology Studies, Radiofrequency and Cryo Ablations, Pacemaker and Internal Cardiac Defibrillator (ICD) implants, Open Heart Surgery, Heart Valve Replacements, Transcatheter Aortic Valve Replacement (TAVR), Lariat and Thoracoscopic MAZE.
SCRI Cardiovascular has conducted more than 120 industry-sponsored clinical trials and enrolled more than 1,500 participants since the program’s inception in 2007. It works with 75 cardiologists in the areas of interventional, electrophysiology, heart failure, imaging and surgery to provide access to novel therapies.
“We are honored to work with Memorial Hospital to provide access to cardiovascular clinical trials. Memorial Hospital has a long-standing expertise in cardiology and we are excited to be able to expand its cardiovascular services,” said Sybil Hyatt, Director of Operations, Cardiovascular at Sarah Cannon. “Our cardiovascular research program is designed to provide state-of-the-art, innovative approaches to clinical trial management and we have an unwavering commitment to the treatment and lives of our patients through clinical research.”